AMPH icon

Amphastar Pharmaceuticals

222 hedge funds and large institutions have $1.06B invested in Amphastar Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 90 increasing their positions, 74 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more ownership

Funds ownership:

1% less capital invested

Capital invested by funds: $1.07B → $1.06B (-$7.7M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

90% less call options, than puts

Call options by funds: $6.06M | Put options by funds: $60.7M

Holders
222
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.06M
Puts
$60.7M
Net Calls
Net Calls Change

Top Buyers

1 +$9.56M
2 +$9.2M
3 +$7.62M
4
Goldman Sachs
Goldman Sachs
New York
+$7.42M
5
CM
Castleark Management
Illinois
+$6.7M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$288K
152
$271K
153
$270K
154
$269K
155
$267K
156
$263K
157
$248K
158
$246K
159
$226K
160
$225K
161
$220K
162
$211K
163
$203K
164
$167K
165
$140K
166
$139K
167
$133K
168
$129K
169
$117K
170
$115K
171
$111K
172
$106K
173
$104K
174
$89K
175
$87K